Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Macleods Pharmaceuticals Ltd
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

MACLEODS PHARMACEUTICALS LTD

www.macleodspharma.com

All Companies ›

Maharashtra ›

Manufacturing of Chemical Products ›

MACLEODS PHARMACEUTICALS LTD

Active

Updated: 25 Feb 2026

Macleods Pharmaceuticals Ltd is a global pharmaceutical company that specializes in developing, manufacturing, and marketing a comprehensive range of generic and branded medications. It offers a diverse portfolio of high-quality products across various therapeutic categories, including anti-infectives, cardiovascular, and central nervous system, focusing on improving patient outcomes and accessibility to essential medicines.

Macleods Pharmaceuticals Ltd, is an unlisted public company incorporated on 05 June, 1989. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 65.00 cr and the total paid-up capital is INR 64.87 cr.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

bi-layered, and enteric coated tablets; hard and soft gelatin capsules, coated, uncoated, dispersible

Company size

Auth Capital

₹ 65.0 Cr

Paidup Capital

₹ 64.9 Cr

Revenue

₹ >5000 cr

Key Metrics

** All rupee values in INR crores. Based on March 2025 numbers.

Total Revenue

4.91%

₹ 9,308.1

EBITDA

7.27%

₹ 2,246.2

Net Profit

11.25%

₹ 2,276.4

Networth

25.5%

₹ 11,222.0

Borrowings

50.37%

₹ 325.2

Assets

25.07%

₹ 13,354.0

Gross Margin

1.41

67.2 %

Operating Margin

-0.15

25.0 %

Net Profit Margin

1.4

24.5 %

Return on Equity

-2.6

20.3 %

ROCE

-7.34

24.8 %

Debt to Equity

0.01

0.0

Sales

Mar 2025

Net worth

Mar 2025

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (55)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Managing Director	Banwarilal Murlidhar Bawri Shareholder	00017795	37 years
Director	Girdharilal Murlidhar Bawri Shareholder	00034197	36 years
Director	Mihir Bipin Shah	07586469	10 years
Director	Arvind Sadashiv Mokashi	09305967	4 years
Director	Vinita Mayur Danait	00216529	4 years
Managing Director	Rajendra Murlidhar Agarwal Shareholder	00034224	37 years

Financial Highlights

** All numbers in INR crores

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	7,174.2	7,462.7	7,813.3	8,333.2	8,991.4
Operating profit	2,408.3	1,559.0	1,431.3	2,094.0	2,246.2
Net profit	2,164.1	1,167.2	1,475.4	2,046.2	2,276.4
Gross margin	69.1	62.4	62.6	65.8	67.2
Operating margin	33.6	20.9	18.3	25.1	25.0
Net margin	27.9	15.4	18.4	23.1	24.5
Networth	10,293.6	5,413.3	6,900.2	8,941.9	11,222.0
Borrowings	113.1	78.1	127.3	216.3	325.2
Assets	11,700.6	6,975.9	8,695.7	10,677.5	13,354.0
Debt to equity	0.0	0.0	0.0	0.0	0.0
Current ratio	7.6	2.7	3.3	4.0	4.6
ROE	21.0	21.6	21.4	22.9	20.3
Days payable	86.0	70.0	74.0	60.0	66.0
WC days	339.0	108.0	162.0	178.0	244.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	20.0	59.9	59.9	64.9	64.9
Reserves	10,273.6	5,353.4	6,840.3	8,877.0	11,157.1
Borrowings +	113.1	78.1	127.3	216.3	325.2
Long term borrowings	33.4	-	-	-	-
Short term borrowings	79.7	78.1	127.3	216.3	325.2
Trade payables +	522.9	536.7	592.3	467.4	537.4
Days payable	86.0	70.0	74.0	60.0	66.0
Other liabilities +	771.0	947.8	1,075.9	1,051.9	1,269.4
Other non-current liabilities	369.8	237.8	258.3	400.4	457.8
Other current liabilities	401.1	710.1	817.6	651.4	811.6
Total liabilities	11,700.6	6,975.9	8,695.7	10,677.5	13,354.0
Fixed Assets +	1,888.0	1,833.9	1,834.6	1,940.2	2,342.1
Tangible assets	1,617.9	1,495.0	1,637.6	1,598.0	1,802.6
CWIP	264.4	334.3	189.9	287.4	526.7
Intangible assets	5.7	4.5	7.1	54.8	12.8
LT loans and advances	9.9	9.0	31.9	24.9	8.4
Other non-current assets	2,135.7	1,597.3	1,818.4	3,309.9	3,306.7
Current assets +	7,667.0	3,535.7	5,010.8	5,402.5	7,696.9
Inventories	1,155.2	1,542.7	1,239.2	1,412.1	1,478.4
Trade receivables	1,645.0	1,260.0	1,126.3	1,234.0	1,489.8
Cash and cash equivalents	155.0	17.8	47.1	33.7	34.1
ST loans and advances	0.4	0.3	0.5	0.6	0.8
Other current assets	4,711.4	715.0	2,597.7	2,722.1	4,693.8
Total assets	11,700.6	6,975.9	8,695.7	10,677.5	13,354.0

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.17	0.86	0.69	0.61	0.49
Reserves	87.8	76.74	78.66	83.14	83.55
Borrowings +	0.97	1.12	1.46	2.03	2.44
Long term borrowings	0.29	0.0	0.0	0.0	0.0
Short term borrowings	0.68	1.12	1.46	2.03	2.44
Trade payables	4.47	7.69	6.81	4.38	4.02
Other liabilities +	11.06	21.28	19.18	14.23	13.53
Other non-current liabilities	3.16	3.41	2.97	3.75	3.43
Other current liabilities	3.43	10.18	9.4	6.1	6.08
Total liabilities
Fixed Assets +	16.14	26.29	21.1	18.17	17.54
Tangible assets	13.83	21.43	18.83	14.97	13.5
CWIP	2.26	4.79	2.18	2.69	3.94
Intangible assets	0.05	0.07	0.08	0.51	0.1
LT loans and advances	0.08	0.13	0.37	0.23	0.06
Other non-current assets	18.25	22.9	20.91	31.0	24.76
Current assets +	65.53	50.68	57.62	50.6	57.64
Inventories	9.87	22.11	14.25	13.23	11.07
Trade receivables	14.06	18.06	12.95	11.56	11.16
Cash and cash equivalents	1.33	0.25	0.54	0.32	0.26
ST loans and advances	0.0	0.0	0.01	0.01	0.01
Other current assets	40.27	10.25	29.87	25.49	35.15
Total assets

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	20.0	59.9	59.9	64.9	64.9
Reserves	9,945.5	4,973.2	6,640.9	8,658.2	10,918.7
Borrowings +	113.1	78.1	127.3	225.1	325.2
Long term borrowings	33.4	-	-	8.8	-
Short term borrowings	79.7	78.1	127.3	216.3	325.2
Trade payables +	667.4	653.5	660.4	542.4	618.0
Days payable	98.0	78.0	80.0	69.0	76.0
Other liabilities +	681.8	1,313.2	1,404.5	1,440.8	1,500.2
Other non-current liabilities	275.9	240.3	260.1	401.4	470.2
Other current liabilities	405.9	1,072.9	1,144.4	1,039.4	1,030.1
Total liabilities	11,427.8	7,078.0	8,893.0	10,931.4	13,427.1
Fixed Assets +	1,904.0	1,845.0	1,841.6	1,962.4	2,366.9
Tangible assets	1,631.0	1,506.2	1,644.5	1,650.9	1,809.2
CWIP	264.4	334.3	189.9	287.4	526.7
Intangible assets	8.5	4.5	7.2	24.1	31.1
LT loans and advances	0.2	0.7	0.4	0.5	0.7
Other non-current assets	2,180.2	1,633.9	1,838.7	3,333.3	3,342.5
Current assets +	7,343.4	3,598.3	5,212.2	5,635.2	7,717.0
Inventories	1,422.5	1,713.7	1,366.8	1,582.0	1,737.7
Trade receivables	996.9	1,097.2	1,115.2	1,225.9	1,174.8
Cash and cash equivalents	199.4	67.6	128.2	100.0	98.4
ST loans and advances	0.4	0.3	0.5	0.6	1.3
Other current assets	4,724.1	719.5	2,601.5	2,726.8	4,704.9
Total assets	11,427.8	7,078.0	8,893.0	10,931.4	13,427.1

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.17	0.85	0.67	0.59	0.48
Reserves	87.03	70.26	74.68	79.2	81.32
Borrowings +	0.99	1.1	1.43	2.06	2.42
Long term borrowings	0.29	0.0	0.0	0.08	0.0
Short term borrowings	0.7	1.1	1.43	1.98	2.42
Trade payables	5.84	9.23	7.43	4.96	4.6
Other liabilities +	11.81	27.79	23.22	18.14	15.78
Other non-current liabilities	2.41	3.4	2.92	3.67	3.5
Other current liabilities	3.55	15.16	12.87	9.51	7.67
Total liabilities
Fixed Assets +	16.66	26.07	20.71	17.95	17.63
Tangible assets	14.27	21.28	18.49	15.1	13.47
CWIP	2.31	4.72	2.14	2.63	3.92
Intangible assets	0.07	0.06	0.08	0.22	0.23
LT loans and advances	0.0	0.01	0.0	0.0	0.0
Other non-current assets	19.08	23.08	20.68	30.49	24.89
Current assets +	64.26	50.84	58.61	51.55	57.47
Inventories	12.45	24.21	15.37	14.47	12.94
Trade receivables	8.72	15.5	12.54	11.21	8.75
Cash and cash equivalents	1.74	0.95	1.44	0.91	0.73
ST loans and advances	0.0	0.0	0.01	0.01	0.01
Other current assets	41.34	10.17	29.25	24.94	35.04
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales +	7,174.2	7,462.7	7,813.3	8,333.2	8,991.4
Sales growth %	8.87	4.02	4.7	6.65	7.9
Expenses +	4,898.0	6,071.0	6,559.3	6,414.6	6,926.6
Cost of goods	2,218.0	2,806.1	2,919.5	2,852.1	2,951.2
Employee cost	1,247.3	1,497.5	1,578.1	1,651.2	1,742.1
Other costs	1,300.5	1,600.1	1,884.3	1,735.9	2,051.8
Operating profit +	2,408.3	1,559.0	1,431.3	2,094.0	2,246.2
Operating margin %	33.6	20.9	18.3	25.1	25.0
Other income	587.7	126.2	213.3	539.0	316.7
Interest	24.7	10.8	7.4	11.6	8.5
Depreciation	107.4	156.6	169.9	163.9	172.9
Exceptional items	-	-	-	-	-
Profit before tax	2,863.9	1,517.8	1,467.4	2,457.5	2,381.5
Tax	699.8	350.6	-8.0	411.3	105.1
Profit - disc. ops	-	-	-	-	-
Net profit	2,164.1	1,167.2	1,475.4	2,046.2	2,276.4
Net margin %	27.9	15.4	18.4	23.1	24.5

Precentage of total income	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	92.43	98.34	97.34	93.92	96.6
Expenses +	63.1	80.0	81.72	72.3	74.41
Cost of goods	28.58	36.98	36.37	32.15	31.71
Employee cost	16.07	19.73	19.66	18.61	18.72
Other costs	16.76	21.08	23.48	19.57	22.04
Operating profit	31.03	20.54	17.83	23.6	24.13
Other income	7.57	1.66	2.66	6.08	3.4
Interest	0.32	0.14	0.09	0.13	0.09
Depreciation	1.38	2.06	2.12	1.85	1.86
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	36.9	20.0	18.28	27.7	25.59
Tax	9.02	4.62	-0.1	4.64	1.13
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	27.88	15.38	18.38	23.06	24.46

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales +	7,312.0	8,207.1	8,171.6	8,667.8	9,357.6
Sales growth %	0.6	12.24	-0.43	6.07	7.96
Expenses +	5,461.8	6,556.3	6,693.2	6,763.5	7,310.3
Cost of goods	2,474.4	3,062.1	3,018.3	2,889.5	2,979.5
Employee cost	1,285.6	1,541.1	1,625.3	1,712.0	1,828.3
Other costs	1,566.8	1,781.9	1,868.9	1,983.6	2,317.0
Operating profit +	1,985.2	1,821.9	1,659.2	2,082.6	2,232.7
Operating margin %	27.1	22.2	20.3	24.0	23.9
Other income	590.6	49.1	200.0	528.7	314.1
Interest	25.1	11.4	7.8	11.7	9.1
Depreciation	109.9	159.8	172.9	166.7	176.4
Exceptional items	-	-72.1	-	-	-
Profit before tax	2,440.8	1,627.9	1,678.4	2,432.9	2,361.3
Tax	588.7	299.6	13.5	415.9	101.8
Profit - disc. ops	-	-99.1	-	-	-
Net profit	1,852.2	1,229.5	1,666.5	2,021.3	2,262.6
Net margin %	23.4	15.1	19.9	22.0	23.4

Precentage of total income	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	92.53	99.4	97.61	94.25	96.75
Expenses +	69.11	79.41	79.95	73.54	75.58
Cost of goods	31.31	37.09	36.05	31.42	30.81
Employee cost	16.27	18.67	19.41	18.62	18.9
Other costs	19.83	21.58	22.32	21.57	23.96
Operating profit	25.12	22.07	19.82	22.65	23.09
Other income	7.47	0.6	2.39	5.75	3.25
Interest	0.32	0.14	0.09	0.13	0.09
Depreciation	1.39	1.94	2.07	1.81	1.82
Exceptional items	0.0	-0.87	0.0	0.0	0.0
Profit before tax	30.89	19.72	20.05	26.46	24.42
Tax	7.45	3.63	0.16	4.52	1.05
Profit - disc. ops	0.0	-1.2	0.0	0.0	0.0
Net profit	23.44	14.89	19.91	21.98	23.39

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Solvency +
Total Debt/Equity	0.0	0.0	0.0	0.0	0.0
Net Debt/Equity	0.0	0.0	0.0	0.0	0.0
Total Debt/Assets	0.0	0.0	0.0	0.0	0.0
Total Assets/Equity	1.1	1.3	1.3	1.2	1.2
Liquidity +
Current Ratio	7.6	2.7	3.3	4.0	4.6
Quick Ratio	6.5	1.5	2.5	3.0	3.7
Interest Coverage	97.5	144.2	192.6	180.3	263.0
Performance
Gross Margin	69.1	62.4	62.6	65.8	67.2
Operating Margin	33.6	20.9	18.3	25.1	25.0
Net Margin	27.9	15.4	18.4	23.1	24.5
Return +
Return on Equity	21.0	21.6	21.4	22.9	20.3
Pre-tax ROCE	26.9	34.7	23.8	32.1	24.8
Return on Assets	18.5	16.7	17.0	19.2	17.1
Pre-tax ROIC	22.4	25.6	18.1	21.1	18.0
Efficiency +
Days Payable	86.0	70.0	74.0	60.0	66.0
Days Inventory	190.0	201.0	155.0	181.0	183.0
Days Receivable	84.0	62.0	53.0	54.0	60.0
Fixed Asset Turnover	3.8	4.1	4.3	4.3	3.8
Total Asset Turnover	0.6	1.1	0.9	0.8	0.7
Working Capital
Cash Conversion Cycle	188.0	193.0	134.0	175.0	177.0
Working Capital Days	339.0	108.0	162.0	178.0	244.0

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Solvency +
Total Debt/Equity	0.0	0.0	0.0	0.0	0.0
Net Debt/Equity	0.0	0.0	0.0	0.0	0.0
Total Debt/Assets	0.0	0.0	0.0	0.0	0.0
Total Assets/Equity	1.1	1.4	1.3	1.2	1.2
Liquidity +
Current Ratio	6.4	2.0	2.7	3.1	3.9
Quick Ratio	5.1	1.0	2.0	2.2	3.0
Interest Coverage	79.0	160.3	213.4	178.0	245.9
Performance
Gross Margin	66.2	62.7	63.1	66.7	68.2
Operating Margin	27.1	22.2	20.3	24.0	23.9
Net Margin	23.4	15.1	19.9	22.0	23.4
Return +
Return on Equity	18.6	24.4	24.9	23.2	20.6
Pre-tax ROCE	23.2	45.7	29.0	33.0	25.4
Return on Assets	16.2	17.4	18.7	18.5	16.9
Pre-tax ROIC	18.8	33.0	22.2	21.6	18.3
Efficiency +
Days Payable	98.0	78.0	80.0	69.0	76.0
Days Inventory	210.0	204.0	165.0	200.0	213.0
Days Receivable	50.0	49.0	50.0	52.0	46.0
Fixed Asset Turnover	3.8	4.5	4.4	4.4	4.0
Total Asset Turnover	0.6	1.2	0.9	0.8	0.7
Working Capital
Cash Conversion Cycle	162.0	175.0	135.0	183.0	183.0
Working Capital Days	309.0	80.0	147.0	162.0	224.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

State Bank of India

No. of Loans: 1

Total Amount : 299.7 cr

Standard Chartered Bank

No. of Loans: 1

Total Amount : 71.5 cr

HDFC Bank Limited

No. of Loans: 1

Total Amount : 59.9 cr

Axis Bank Limited

No. of Loans: 1

Total Amount : 50.0 cr

Charge Holder	Amount	Date of creation/modification
State Bank of India	299.7 cr	07 Dec, 2021
Standard Chartered Bank	71.5 cr	31 Jul, 2021
HDFC Bank Limited	59.9 cr	21 Jun, 2021
Axis Bank Limited	50.0 cr	26 Apr, 2021

Charges

State Bank of India

Standard Chartered Bank

HDFC Bank Limited

Axis Bank Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
AGARWAL HOLDINGS PRIVATE LIMITED	Active	20.0 Cr	4	Maharashtra
MACLEODS LABORATORIES PRIVATE LIMITED	Active	1.2 L	2	Maharashtra
KALYANKRIT INDUSTRIES PRIVATE LIMITED	Active	50.0 L	3	Maharashtra
AGARWAL HOLDINGS PRIVATE LIMITED	Active	20.0 Cr	4
EAST AND WEST CLOTHING PRIVATE LIMITED	Active	15.0 L	2	Maharashtra
RATNIDEVI MURLIDHAR BAWRI SOCIAL WELFARE FOUNDATION	Active	1.0 L	2	Maharashtra
KAN CONSULTANCY SOLUTIONS PRIVATE LIMITED	Strike Off	7.5 L	1	Maharashtra
PMEA SOLAR SYSTEMS PRIVATE LIMITED	Active	10.5 Cr	1	Maharashtra
PMEA SOLAR TECH SOLUTIONS LIMITED	Active	112.4 Cr	1	Maharashtra
INDIA DEBT RESOLUTION COMPANY LIMITED	Active	20.0 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Macleods Pharma Espana S L U, Spain	Spain	-	-
Macleods Pharmaceuticals, LLC, Ukraine	Ukraine	-	-
Macleods Pharmaceuticals SA (Pty.) Ltd., South Africa	South Africa	-	-
Macleods Pharma USA INC., USA	United States	-	-
Macleods Pharma UK Ltd., UK	United Kingdom	-	-
Makmed LLC	Russian Federation	-	-
Oxus Pharma Ltd	Nigeria	-	-
Macleods Pharmaceuticals Philippines,inc	Philippines	-	-
Macleods Pharmaceuticals SDN BHD	Malaysia	-	-
Macleods Pharmaceuticals Philippines inc	Philippines	-	-

Tofler Score

Excellent

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

HIGH INVENTORY
ROCE DETERIORATING

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U24239MH1989PLC052049

PAN

AAACM4100C

Incorporation

1989, 36.9 years

Company Email

roc[at]macleodspharma[dot]com

Paid up Capital

₹ 64.9 Cr

Authorised Capital

₹ 65.0 Cr

AGM

Sep 2024

Type

Public

Others

FAQ - MACLEODS PHARMACEUTICALS LTD

What is the incorporation date of MACLEODS PHARMACEUTICALS LTD?

The incorporation date of MACLEODS PHARMACEUTICALS LTD is 05 June, 1989

What is the authorized share capital of MACLEODS PHARMACEUTICALS LTD?

The authorized share capital of MACLEODS PHARMACEUTICALS LTD is INR ₹ 65.0 Cr.

What is the paid-up capital of MACLEODS PHARMACEUTICALS LTD?

The paid-up capital of MACLEODS PHARMACEUTICALS LTD is INR ₹ 64.9 Cr.

What is the registered address of MACLEODS PHARMACEUTICALS LTD?

The registered address of MACLEODS PHARMACEUTICALS LTD is 304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST), MUMBAI, Maharashtra, India, 400059 - 400059

What is the CIN number of MACLEODS PHARMACEUTICALS LTD?

The CIN number of MACLEODS PHARMACEUTICALS LTD is U24239MH1989PLC052049.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

MACLEODS PHARMACEUTICALS LTD

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

Company Network